IL-6 exerts its effects through the activation of several oncogenic pathways, including JAK/STAT3, PI3K/Akt, and MAPK, which promote tumor cell proliferation, inhibit apoptosis, and enhance metastatic potential. Here, STAT3 is linked to neoplasm.